Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$368K Buy
4,262
+214
+5% +$19.7K ﹤0.01% 1286
2026
Q1
$357K Buy
4,048
+567
+16% +$46K ﹤0.01% 1179
2025
Q4
$226K Buy
3,481
+30
+0.9% +$2.72K ﹤0.01% 1327
2025
Q3
$514K Buy
3,451
+31
+0.9% +$4.54K ﹤0.01% 960
2025
Q2
$497K Buy
3,420
+105
+3% +$15.2K ﹤0.01% 951
2025
Q1
$419K Buy
3,315
+194
+6% +$24.5K ﹤0.01% 986
2024
Q4
$324K Buy
3,121
+346
+12% +$32.9K ﹤0.01% 1102
2024
Q3
$237K Buy
+2,775
New +$214K ﹤0.01% 1164

Other funds holding LRN

Xponance's LRN Position: Q2 2026 in Review

Xponance increased its Stride (LRN) stake by 5.3% in Q2 2026, buying an estimated $19.7K and bringing the position to 4,262 shares worth $368K. The position accounts for ﹤0.01% of the portfolio, ranked #1286.

Xponance first reported a position in LRN in Q3 2024 and has held it in 8 quarters since. The position peaked at $514K in Q3 2025. 413 funds tracked by Wall St. Rank hold LRN as of Q2 2026.

  • Xponance held 4,262 shares of Stride worth $368K as of Q2 2026.
  • Xponance bought 214 Stride shares in Q2 2026, an estimated $19.7K.
  • Stride made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1286 holding.
  • Xponance first reported a position in Stride in Q3 2024 and has held it in 8 quarters since.
  • Xponance's Stride position peaked at $514K in Q3 2025.
  • 413 funds tracked by Wall St. Rank held Stride as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.